ctrl K

AI Score

Unlock

Compass Therapeutics Inc. (CMPX)

AI Score

Unlock

2.88

-0.04 (-1.37%)

At close: Feb 28, 2025, 3:59 PM

2.85

-1.21%

After-hours: Feb 28, 2025, 05:45 PM EST

Compass Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.89M	1.9M	1.62M	2.4M	2.12M	1.92M
Gross Profit	-1.89M	-1.9M	-1.62M	-2.4M	-2.12M	-1.92M
Operating Income	-50.36M	-41.66M	-81.88M	-27.81M	-34.05M	-38.31M
Interest Income	n/a	2.36M	29K	88K	743K	663K
Pretax Income	-42.49M	-39.23M	-82.18M	-29.47M	-34.65M	-38.18M
Net Income	-42.49M	-36.8M	-82.55M	-29.5M	-34.74M	-38.29M
Selling & General & Admin	11.05M	11.66M	10.93M	12.91M	11.6M	11.22M
Research & Development	37.42M	30M	20.34M	14.9M	22.45M	27.09M
Other Expenses	n/a	n/a	50.62M	n/a	n/a	n/a
Operating Expenses	48.47M	41.66M	31.26M	27.81M	34.05M	38.31M
Interest Expense	n/a	2.36M	370K	908K	1.23M	767K
Selling & Marketing Expenses	11.04M	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	50.36M	41.66M	31.26M	27.81M	34.05M	38.31M
Income Tax	n/a	-2.43M	370K	32K	91K	103K
Shares Outstanding (Basic)	127.03M	105.19M	62.87M	30.78M	52.11M	52.11M
Shares Outstanding (Diluted)	127.03M	105.19M	62.87M	30.78M	52.11M	52.11M
EPS (Basic)	-0.33	-0.35	-1.31	-0.96	-0.67	-0.73
EPS (Diluted)	-0.33	-0.35	-1.31	-0.96	-0.67	-0.73
EBITDA	-48.47M	-37.39M	-29.61M	-25.32M	-31.19M	-35.73M
Depreciation & Amortization	1.89M	1.9M	1.62M	2.4M	2.12M	1.92M